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Abstract
The thymic stroma supports T lymphocyte development and consists of an epithelium maintained by thymic epithelial
progenitors. The molecular pathways that govern epithelial homeostasis are poorly understood. Here we demonstrate that
deletion of Rac1 in Keratin 5/Keratin 14 expressing embryonic and adult thymic epithelial cells leads to loss of the thymic
epithelial compartment. Rac1 deletion led to an increase in c-Myc expression and a generalized increase in apoptosis
associated with a decrease in thymic epithelial proliferation. Our results suggest Rac1 maintains the epithelial population,
and equilibrium between Rac1 and c-Myc may control proliferation, apoptosis and maturation of the thymic epithelial
compartment. Understanding thymic epithelial maintenance is a step toward the dual goals of in vitro thymic epithelial cell
culture and T cell differentiation, and the clinical repair of thymic damage from graft-versus-host-disease, chemotherapy or
irradiation.
Citation: Hunziker L, Aznar Benitah S, Braun KM, Jensen K, McNulty K, et al. (2011) Rac1 Deletion Causes Thymic Atrophy. PLoS ONE 6(4): e19292. doi:10.1371/
journal.pone.0019292
Editor: Sean Bong Lee, The National Institute of Diabetes and Digestive and Kidney Diseases, United States of America
Received August 5, 2010; Accepted April 1, 2011; Published April 29, 2011
Copyright:  2011 Hunziker et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: SAB, KMB, NW, and FMW were supported by Cancer Research UK (http://www.cancerresearchuk.org). LH was supported by the following grants: Swiss
national foundation PBBSB-108681, the Freiwillige Akademische Gesellschaft and the Margarete und Walter Lichtenstein Stiftung. KMB was supported by
EuroStemCell (http://www.eurostemcell.org/). KM is an MRC Clinical Training Fellow (http://www.mrc.ac.uk/index.htm). SMJ is a Wellcome Senior Fellow in Clinical
Science (WT091730MA)(http://www.wellcome.ac.uk/). This work was partially undertaken at UCLH/UCL who received a proportion of funding from the
Department of Health’s NIHR Biomedical Research Centre’s funding scheme. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: s.janes@ucl.ac.uk
. These authors contributed equally to this work.
Introduction
The thymus is an epithelial organ responsible for T cell survival,
maturation and selection [1]. It is formed by a cortex and medulla
containing epithelial cells that are morphologically and function-
ally distinct [1,2,3]. Cortical epithelial cells support positive
selection from immature CD4+/CD8+ thymocytes [4,5,6] while
medullary epithelial cells enable induction of tolerance [7,8]. A
putative embryonic epithelial progenitor exists that is defined by
cell surface expression of the glycoprotein MTS24 and EpCAM1
[9,10,11]. Transplantation experiments show that low numbers of
MTS24+ epithelial cells taken from embryonic thymus, between
gestational days 11.5–15.5, are capable of forming a fully func-
tioning thymus with all epithelial subtypes, attract lymphoid
progenitors and support CD4+/CD8+ lymphopoiesis [9,10]. The
use of MTS24 as a stem cell marker is however debated [12] but
further progress has been made by lineage tracing single
transplanted cells. Two studies using elegant lineage tracing
techniques have established two populations capable of self-
renewal and differentiation into medullary and cortical thymic
epithelial cells (TECs) [13,14]. One population is derived from
embryonic day 12 (E12) thymic epithelium expressing EpCAM1
(these cells also express MTS24 and cytokeratin 5 (K5)) [14]. A
second population capable of multipotent differentiation into both
medullary and cortical epithelium is derived from post-natal
medullary cells expressing cytokeratin 14 (K14), the K5 hetero-
dimer [13]. This was demonstrated using lineage tracing driven by
the Keratin 14 promotor. The thymic epithelial Keratin 14
expressing cells were typically thought confined to the thymic
medulla however lineage tracing demonstrated colonies that were
either medullary, cortical or mixed [13].
Several transcription factors required for thymic organogenesis have
been identified [15,16,17,18]. The best understood factor controlling
murine thymic epithelial differentiation is Foxn1. Foxn1 is thought to be
required at the onset of differentiation and Foxn12/2 mice develop
epithelial cysts without thymopoiesis [13,18,19]. Foxn12/2 epithelium
appears immature and it has been suggested that it is required for the
onset of normal thymic epithelial cell differentiation [18]. Replacement
of Foxn1 in single cells results in repopulation of small areas of thymic
tissue capable of thymopoiesis [13].
In contrast, very little is known regarding the factors that
maintain the thymic stem/progenitor cell compartment or
mediate differentiation into the major thymic epithelial subsets
of cortex and medulla. Recently it has been shown that p63 is
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dispensable for lineage commitment and differentiation during
thymic organogenesis, but is required to maintain the proliferative
potential of thymic epithelial progenitors [20,21]. Furthermore,
p63 appears to mediate survival of thymic epithelial stem cells in
vivo by providing protection from programmed cell death [21]. It
is predicted that the loss of stem cells would lead to the natural
history of thymic involution, but it remains to be determined how
the balance between proliferation and apoptosis is regulated
during the process of ageing.
Rac1 plays essential roles in T-cell development and homeo-
stasis [22]. For instance, pre-T cell differentiation and proliferation
upon T cell antigen receptor (TCR) beta selection is dependent on
Rac1 and its upstream activator Vav1 [23]. Interestingly,
activation of Rac1 efficiently diverts pre-T cells from positive
selection in the medulla into negative selection and subsequent
deletion [24]. It has been postulated that Rac1 signals downstream
of a6b4 integrin and p38MAPK in thymic epithelial cells to
promote secretion of IL6 upon thymocyte contact [25]. However,
the specific role of Rac1 in the epithelial compartment of the
thymus has not yet been defined.
We wished to determine whether Rac1 has a role in the
maintenance of the thymic epithelial cell compartment. We first
deleted Rac1 in post-natal K14 expressing epithelial cells. Upon
deletion these mice underwent a degree of thymic atrophy. We then
found in an engraftment model that the deletion of Rac1 in K14
positive embryonic cells resulted in a failure of thymic organogenesis.
K5 and K14 are heterodimers and hence we then used a constitutive
model of K5 driven Rac1 deletion to confirm our results. The
embryonic thymus at E12 is made up of a homogenous population of
immature cells characterized by their expression of a series of proteins
including EPCAM1, MTS24 and K5 and K8 [14,26,27]. Here we
show embryonic deletion of Rac1 in K5 cells (which includes the
progenitor populations [14]) leads in most cases to athymia or
catastrophic thymic atrophy with loss of the medullary-cortical
architecture. This atrophy may be due to a Rac1 mediated up-
regulation of c-Myc leading to a global increase in apoptosis.
Materials and Methods
Ethics Statement and Experimental mice
All animal experiments were performed in compliance with Home
Office and institutional guidelines. To lineage trace the K14 promoter
K14CreER (kind gift from B. Stripp [28]) were crossed with CAG-
CAT-eGFP (kind gift from J. Miyazaki [29]). Homozygous floxed
Rac1 mice (Rac1flox/flox) and heterozygous for K14CreER
(K14CreERxRac1flox/flox) or K5Cre (K5CrexRac1flox/flox) were
generated as described previously [30,31]. Briefly embryonic deletion
of Rac1 was achieved by crossing Rac1flox/flox mice [32] together with
Keratin5-Cre (K5Cre) mice [33,34]. Specifically, we first crossed
K5Crehet to Rac1flox/flox to obtain K5CrehetxRac1flox/wt. We then
crossed K5CrehetxRac1flox/wt mice with Rac1flox/flox to obtain
K5CrehetxRac1flox/flox knock-out mice (K5CrexRac1flox/flox). Deletion
of Rac1 in adult thymus was obtained by crossing K14CreERhetx-
Rac1flox/wt mice with Rac1flox/flox mice (K14CreERxRac1flox/flox)
[28,30]. Cre-mediated deletion of Rac1 in K14CreERxRac1flox/flox
mice, and the stop signal in the K14CreER6CAG-CAT-eGFP
reporter mice, was induced by weekly administration of 5 mg of
intraperitoneal tamoxifen in 100 ml of peanut oil (Sigma) for three
weeks. Thymic grafts were placed in female ICRF nu/nu mice kept in
filtered sterile cages.
Foetal Thymic Organ Cultures
Thymic lobes were removed from E15.5 embryos and cultured in
complete medium (RPMI with 10% FCS, 2 mM glutamine, 10 mM
HEPES), with or without 100 nM 4-hydroxy-tamoxifen. Lobes were
then removed from culture and prepared for frozen sectioning.
Antibodies
Antibodies against Rac1 (Clone 23A8, Upstate Biotechnology,
1:100 dilution), Ki67 (Novacastra, 1:400 dilution), Keratin 14
(Babco, 1:1000), Keratin 5 (Abcam, 1:1000), Keratin 8 (Abcam,
1:1000), phospho-serine 20-PAK2 (US Biologicals, 1:100), GFP
(ab5450, Abcam, 1:500), c-Myc (N262, Santa Cruz, 1:100), anti-ER
(HL7, 1:100), and MTS24 (1:100) [9] were used for immunoflu-
orescence as previously described [28,30]. Secondary antibodies for
immunofluorescence conjugated to Alexa-488, Alexa-594 and
Alexa-633 were purchased from Molecular Probes and used at a
1:400 dilution. Nuclei were counter- stained with DAPI or To-Pro-3
(Invitrogen). APC conjugated anti-mouse CD8, FITC conjugated
anti-mouse CD3 and PE conjugated anti-mouse CD4 were used for
splenic and thymic cell flow cytometry (BD Pharminogen).
Primary Thymic Epithelial Cell Harvest and Kidney
Capsule Grafting
Primary thymic epithelial cells were harvested as described
elsewhere [35]. Cells were derived from E13.5 stage mouse embryos.
2000 MTS24+ and 25000 MTS242 cells were sorted by fluorescence
activated cell sorting. Cells were resuspended in a small volume of
RPMI and placed on a fragment of filter paper for 24 hours with or
without 100 nM 4-hydroxy-tamoxifen (Sigma). The paper and cells
were then implanted beneath the kidney capsule of ICRF nu/nu
mice and harvested after 8 weeks. The thymus was taken for
immunohistochemistry and the spleens for flow cytometry.
Immunofluorescence Staining
Thymus was embedded in OCT compound (Bayer) and 5 mm
frozen sections cut. Frozen sections for Rac1 staining were thawed
at room temperature, fixed in 4% paraformaldehyde/2% acetic
acid in PBS for 30 minutes followed by 2 minutes in ice cold
ethanol/acetic acid (95/5). All other sections were fixed in 4%
paraformaldehyde for 20 minutes at room temperature and
permeabilised for 5 minutes in 0.3% Triton X 100. Staining was
analysed using a Leica TCSNT confocal microscope. Proliferating
epithelial cells were only counted if the epithelial marker clearly
surrounded a Ki67 positive nucleus.
MTS24 FACS sorting
Thymic epithelial cell isolation was performed as described [9].
Briefly, five to eight small incisions were made in each isolated
thymic lobe. The tissue was then stirred for 1 h at 4uC in serum-
free RPMI-1640. Remaining tissue aggregates were digested to
single-cell suspension by incubation at 37uC with 0.01% DNase I
and 0.15% collagenase D. Cells from the suspension were washed
in cold FACS buffer and subsequently stained with anti-MTS24
antibody and sorted using a FACScalibur II sorter.
Statistics
Statistical analysis was performed with the one-tailed Mann-
Whitney U test using GraphPad Prism3.00 for Windows
(GraphPad Software). P,0.05 was interpreted as statistically
significant.
Results
Keratin and Rac1 expression in murine thymus
Medullary TECs express K14 and K5 throughout the thymic
medulla (Figure 1A–F and J–L) [10]. K14 and K5 expressing cells
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are not exclusive to the medulla however with positive cells
scattered throughout the cortex (Figure 1G–I). Rac1 staining
shows expression in the majority of cells within the thymus
(Figure 1M) but the immunofluorescence is brightest in epithelial
cells (Figure 1N and O). Therefore, Rac1 is widely expressed
throughout the thymus although brightest in the medullary
epithelia.
In the following experiments we wished to examine the effects of
deleting Rac1 in K14/K5 positive thymic epithelial cells. To this
end we used a Cre/loxP system targeted by the human K14 and
K5 promoters. To demonstrate the targeting using this system we
crossed K14CreER mice with the CAG-CAT-GFP reporter mice.
Hence on activation of the ER receptor the Cre-recombinase will
activate the expression of GFP. Mice received weekly injections of
Figure 1. Keratin and Rac1 expression in the thymus. (A–F and J–L) K14 and K5 largely co-localise in medullary epithelium; dotted lines in D–F
denote medullary-cortical boundary. (G–I) Thymic cortex with scattered K14 and K5 positive cells. (M–O) Rac1 staining is widespread in the thymus
(epithelial cells and thymocytes (M)) but the brightest Rac1 staining co-localises with K14 positive epithelial cells of the medulla, (N and O). (P and Q)
demonstrate K14 positive epithelial cells that are GFP positive in K14 lineage tracing analysis, but no GFP positive cells in the K8 stained cells (R). Scale
bars (A–C) 100 mm, (D–I, M and R) 50 mm, (J–L, N and O) 20 mm, (P–R) 5 mm.
doi:10.1371/journal.pone.0019292.g001
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5 mg tamoxifen for three weeks. Immunofluorescent staining of
thymi from four mice confirmed expression of GFP in K14
positive cells but not in K8 cells (Figure 1P–R). GFP was detected
in 22.2%64.5 (SD) of K14 positive cells with double immunoflu-
orescence (n = 4 mice).
Adult thymic Rac1 depletion results in loss of thymic
tissue
We wished to investigate whether Rac1 had a role in adult
thymic epithelial cell homeostasis. For these experiments we used
K14CreERxRac1flox/flox mice. We compared mice treated with
tamoxifen (activating Cre recombinase) to control mice consisting
of untreated K14CreERxRac1flox/flox mice or litter mates that
were Cre negative with and without tamoxifen.
After three weeks of tamoxifen treatment we observed a
significant decrease in thymic weight in 8 week old K14CreERx-
Rac1flox/flox mice (mean 6 SD; 14.3 mg67.8) compared to
untreated K14CreERxRac1flox/flox mice (27 mg62.7; (p,0.05)),
and tamoxifen treated and untreated Cre negative littermates
(27.0 mg63.6 (p,0.05), and 30.3 mg62.9 (p,0.05) respectively)
(n= 5 per group) (Figure 2A). Rac1 deletion was confirmed by
immunofluorescence (Figure 2B and C). Histological analysis of
tamoxifen treated K14CreERxRac1flox/flox mice revealed destruc-
tion of the medullary-cortical architecture with loss of medulla
compared to littermate controls (Figure 2D–G and Fig. S1 A–H).
FACS analysis of peripheral T cells from spleens showed normal
distribution of CD4+ and CD8+ T cells in tamoxifen treated
K14CreERxRac1flox/flox mice (data not shown), however there was
a block in thymic T cell maturation with an increase in the number
of CD42/CD82 premature T cells (Figure S1 M–O and Table S1).
Rac1 is required for thymic organogenesis
The thymic atrophy induced by Rac1 deletion in adult K14
positive cells led us to predict that we could block thymic
organogenesis by embryonic deletion of Rac1. To do this we
initially used MTS24 expression to fluorescence activated cell sort
for embryonic (E13.5) thymic epithelial cells from wild-type and
K14CreERxRac1flox/flox mice. A majority of epithelial cells are
MTS24 positive in the E13.5 thymus [36]. Purified MTS24+ and
MTS242 cells were incubated for 24 hours with or without 4-
hydroxy-tamoxifen (4OHT) (or vehicle) and underwent hetero-
topic transplantation under the kidney capsule of athymic ICRF
nude mice. 4OHT treated wild-type MTS24+ (4 of 6 mice, not
shown) and non-treated K14CreERxRac1flox/flox MTS24+ cells (5
of 6, Figure 3A) regenerated a functional thymic microenviron-
ment as shown by K5 and K14 expression (Figure 3C–E), the
generation of CD4+ (Figure 3F) and CD8+ cells (Figure 3G) and
flow cytometry of the spleen showing mature T cells (CD3+CD4+
and CD3+CD8+ T cells) derived from the engrafted thymus in the
these nude mice (Figure 3H). However, 4OHT treated, and
therefore Rac1 depleted K14CreERxRac1flox/flox cells were
incapable of thymic organogenisis (0 of 6, Figure 3B) and had
no evidence of mature T cells (Figure 3I) comparable to NOD/
SCID untransplanted controls (Figure 3J) and Table 1. MTS242
cells were also not able to regenerate a thymic microenvironment
(0 of 6, not shown). This experiment confirms that deletion of
Rac1 from embyronic thymic epithelia leads to failure of thymic
organogenesis.
Embryonic Rac1 depletion results in catastrophic loss of
thymic tissue
In order to confirm the importance of Rac1 in the epithelial
homeostasis of the thymus, we next deleted Rac1 in embryonic
thymic epithelial cells using a constitutive model. In these
experiments K5CrexRac1flox/flox mice (K5 is the K14 heterodi-
mer) were compared to their Cre negative littermates. Of 21
K5CrexRac1flox/flox mice born, 16 were completely athymic and 5
had thymic remnants. The weight of K5CrexRac1flox/flox thymus
was 1.04 mg 63.28 (mean 6 SD) (all mice, athymic included)
Figure 2. Effects of adult epithelial Rac1 deletion on thymus
homeostasis and architecture. (A) Reduced weight of tamoxifen-
treated K14CreERxRac1flox/flox (K14+Tam) compared to controls: no
tamoxifen treated K14CreERxRac1flox/flox (K142Tam), tamoxifen treated
and untreated no Cre litter mates (wt+Tam and wt2Tam respectively);
p,0.05). (B and C) Rac1 immunofluorescence demonstrating Rac1 deletion
in the K14+Tam (C) compared to untreated control (B). (D and E) Normal
medullary-cortical architecture of untreated K14CreERxRac1flox/flox mice
(K142Tam). (F and G) Loss of distinct medullary/cortical boundaries after
three weeks in tamoxifen treated K14CreERxRac1flox/flox mice (K14+Tam).
(B and D64 and C and E610).
doi:10.1371/journal.pone.0019292.g002
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Figure 3. Rac1 deletion results in the inhibition of thymic ontogeny. 4-hydroxy-tamoxifen treatment of K14CreERxRac1flox/flox MTS24+ E13.5
thymic epithelial cells (Rac1KO/4OHT+) blocks the generation of a thymic microenvironment after heterotopic transplantation under the kidney
capsule (B) compared to untreated controls (Rac1KO/4OHT2 shown) (A). (C–E) K5 and K14 staining confirming the presence of thymic medullary
epithelial cells in control cells (shown are untreated MTS24+ K14CreERxRac1flox/flox (Rac1KO/4OHT2))which were capable of generating a functional
thymic microenvironment as indicated by the presence of CD4+ (C) and CD8+ cells. (A and B620); Scale bars (C and D) 20 mm. FACS analysis of
splenocytes derived from nude mice grafted with K14CreERxRac1flox/flox MTS24+cells in absence of Tamoxifen showed peripheral CD4 and CD8
positive populations confirming the function of the thymic grafts (H) while with tamoxifen treated mice (I) showed no maturation of peripheral
lymphocytes consistent with untansplanted nude mice (J). The dot plots show cells labelled with anti-CD4 and anti-CD8 antibodies gated on a CD3+
population.
doi:10.1371/journal.pone.0019292.g003
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compared to 41.8 mg67.3 of the litter mate controls (p,0.01)
(Figure 4A). Histological analysis of the five K5CrexRac1flox/flox
mice with thymic tissue at 6 weeks revealed complete loss of the
medulla compared to littermate controls (Figure 4B and 4C).
Immunofluorescence demonstrated a loss in K5 expressing thymic
epithelial cells with a correspondingly depleted Rac1 compared to
litter mate controls (Figure 4D–I and Figure S1 I–L). Immature
thymocytes similar to the K14CreERxRac1flox/flox tamoxifen
treated mice were again demonstrated (Supplementary Figure
S1M–O).
These results show that Rac1 depletion in both mouse models
leads to the loss of thymic epithelial cells and destruction of the
normal thymic architecture.
Rac1 depletion leads to a loss of epithelial proliferation,
increased apoptosis and high c-Myc
immunofluorescence
Rac1 deletion led to a clear reduction in the proportion of Ki67
positive cells across the thymus, including epithelial cells, in tamoxifen-
treated K14CreERxRac1flox/flox mice compared to controls (total
proliferating cells (thymocytes and epithelial cells) 7.0%65.0 compared
to 18.5%62.0 (p,0.05); and proliferating epithelial cells 0% compared
to 11%63.6 (p,0.05) (Figure 5A and 5B). Loss of proliferation was
accompanied by an induction of apoptosis, measured by TUNEL
assay, in both epithelial and non-epithelial cells (probably precursor T
cells). In littermate controls 6.5%62.4 of total cells were TUNEL
positive (Figure 5C) compared to K14CreERxRac1flox/flox mice
tamoxifen-treated for 12 days (63.8%68.3; p,0.05, Figure 5D) and
20 days (70.5%67.8; p,0.05, Figure 5E).
Deletion of Rac1 in keratin-14 or keratin-5 positive epidermal
basal cells results in progressive loss of the entire epidermal
compartment [30,31]. Rac1 null keratinocyte stem cells irreversibly
commit to terminal differentiation (a process with strong similarities
to apoptosis [37]) in a PAK2- and c-Myc-dependent manner [30].
We hypothesised this was also the case in the thymus. Very few c-
Myc positive cells could be detected in the thymus by immunoflu-
orescent staining of wild type 6 week old litter mate mice however
the remnants of thymic epithelium of K5CrexRac1flox/flox mice
showed a marked increase (Supplementary Figure S2A–D).
Similarly, un-treated fetal thymic organ cultures (FTOC) of
K14CreERxRac1flox/flox mice showed low expression of c-Myc
(17.9%67.3; Supplementary Figure S2E), however K14CreERx-
Rac1flox/flox derived FTOC in the presence of 4OHT resulted in up-
regulation of c-Myc immunofluorescent nuclei (51.1%68.4;
p,0.05; Figure S2F). These data suggest the possibility that the
thymic epithelium may have similar homeostatic mechanisms to the
epidermis and is an avenue we are further investigating.
Discussion
Using two different transgenic mice we provide evidence that
Rac1 is important in thymic epithelial cell homeostasis. To
determine whether Rac1 is required for adult thymus homeostasis
we used a model of conditional deletion of Rac1 in post-natal
mice. Here we targeted K14 expressing cells. K14 is expressed in
medullary epithelial cells which include a population shown to
include adult thymic progenitor cells [13]. After Rac1 deletion we
saw a reduction in thymic size and destruction of the medullary-
cortical architecture. In the K5CrexRac1flox/flox transgenic mouse
(K5 is the K14 heterodimer), where Rac1 is deleted after
embryonic expression of K5 (E12.5), 16 of 21 mice were athymic
and the remaining 5 showed a greatly reduced thymic size. In the
5 mice that had a remnant thymus there was gross destruction of
the normal medullary-cortical architecture with loss of the
medulla.
EpCAM1 and MTS24 are expressed by embryonic day 12
(E12) and the K5/K14 heterodimer around E12.5 [9]. In the
embryo, MTS24+K5+ cells are believed to be progenitors of both
cortical and medullary thymic epithelial cells. In our experiments
not all K5CrexRac1flox/flox were however athymic. Due to the
slightly delayed expression of K5, and the presence of a population
that is MTS24+/K8+/K52, it is possible that a delayed or
inefficient deletion of Rac1 in thymic stem cells led to the
generation of a small thymus, or the expansion of the MTS24+/
K8+/K52 population. In the majority of mice however, it appears
that the deletion of Rac1 induces global epithelial cell differen-
tiation or apoptosis.
We used two models of Rac1 deletion to underline the
importance of Rac1 in thymic epithelial cell homeostasis. The
K14 promotor driven system is conditionally active allowing us to
target K14 positive cells in the adult thymus with the majority of
K14 positive cells in the medulla. Recently it has been
demonstrated that a population of postnatal K14 expressing cells
can act as adult progenitors and form medullary, cortical or mixed
cell daughters [13]. While our experiment may target this small
population of adult progenitors of the medulla and cortex, the
activation of Cre after tamoxifen administration in our system of
Rac1 deletion activated Cre in a large number of K14 expressing
cells resulting in the rapid phenotype demonstrated on Cre
activation.
The K5 transgenic system is constitutive and will be activated in
the embryonic thymus. It has been demonstrated that K5 co-
localises with K8 and the putative thymic progenitor marker
MTS24 at E12.5. In the adult, K5 positive cells are largely located
within the medulla. However a significant population of adult K5
positive cells lie within the cortex [26]. These adult cortical thymic
K8+K5+ cells contain precursors that give rise to the major
cortical K8+K52 subset. We therefore anticipate that the
constitutive deletion of Rac1 in K5 expressing cells from E12.5
will target a wide selection of thymic epithelial cells including both
embryonic thymic progenitors, differentiated medullary cells and
adult cortical precursors.
Additional evidence lending support to Rac1 deletion causing
failure of thymic ontogeny seen in the K5CrexRac1flox/flox mice
Table 1. Proportions of CD3 and CD4 positive cells in the spleens of transplanted NOD/SCID mice.
CD4/CD8 status ICRF nu/nu+K14 no tamoxifen ICRF nu/nu+K14+tamoxifen ICRF nu/nu untreated
CD3+CD4+CD8+ 0.72%+/20.14 0.12%+/20.1 0.3%+/20.2
CD3+CD4+CD82 67.9%+/22.2 5.8%+/23.8 5.1%+/22.7
CD3+CD42CD8+ 24.9%+/20.1 5.7%+/22.7 12.8%+/25.0
CD3+CD42CD82 6.5%+/22.1 88.5%+/25.6 81.9%+/27.3
doi:10.1371/journal.pone.0019292.t001
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was gained by using heterotopic transplantation of embryonic
thymic cells from the K14CreERxRac1flox/flox mice. We used
MTS24 expression to sort epithelial cells and deletion of Rac1
blocked the regeneration of a new thymic microenvironment when
transplanted under the kidney capsule. Importantly the MTS24
negative cell population used in our controls includes non-
epithelial cells and hence differs from that previously used by
Rossi and colleagues where a second epithelial marker was used
(Epcam1) to ensure MTS24- epithelial cells were used [12]. These
experiments combined with the K14 litter mates controls supplied
important controls for Cre expression and tamoxifen treatment.
A recent paper has questioned whether the MTS24 marker
uniquely identifies a thymic progenitor subpopulation with the
ability to repopulate functional thymic epithelium [12]. These
differences from previous reports [9,10] are likely due to different
sorting strategies and differing numbers of cells implanted.
Importantly, in our studies we implanted a low number of cells
that were confirmed simply as epithelial based on MTS24
expression. We have demonstrated that Rac1 expression is
required for this subset of epithelial cells to regenerate the thymic
microenvironment.
It has been proposed that Rac and Myc represent a global stem
cell regulatory axis [30]. In the epidermis Rac1 deletion leads to
loss of stem cells while acute Myc over-expression promotes
epidermal and hematopoietic differentiation, possibly through
disruption of cellular adhesion [30,38,39,40,41]. Conversely, in
the gut Myc determines self renewal while loss of Rac1 triggers
differentiation [42]. In other models sustained induction of Myc
Figure 4. Effects of embryonic Rac1 deletion on thymus ontogeny. (A) Reduced weight of K5CrexRac1flox/flox (K5 KO) thymus compared to
Cre negative litter mate controls (ctrl) (error bars are Standard Errors). (B and C) Destruction of distinct medullary/cortical boundaries in
K5CrexRac1flox/flox mice (K5-KO) (B) leaving predominantly K8 positive cortex (C). (D–I) Cre negative littermates (ctrl, D–F) have normal Rac1 and K5
expression compared to reduced expression in K5CrexRac1flox/flox (K5-KO) mice (G–I). (B)610 and (C)620. Scale bars 50 mm.
doi:10.1371/journal.pone.0019292.g004
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leads to tumor development [43]. Hence it is known from other
epithelial systems that Myc regulation is tightly controlled to avoid
differentiation of stem cells or tumorigenesis. To determine
whether a Rac1-Myc axis may be involved in thymic epithelial
homeostasis, we showed in Fetal Thymic Organ Cultures derived
from K14CreERxRac1flox/flox mice and six week old K5Crex-
Rac1flox/flox thymus that Rac1 deletion leads to an increase in c-
Myc expression. While this is not conclusive evidence that the
same regulatory pathways are operational in the thymus as the
skin we believe this will be an interesting line of future
investigation.
In conclusion deletion of Rac1 results in the failure of thymic
ontogeny in embryos and thymic atrophy in adults. Understanding
mechanisms of thymic stem cell maintenance may help the
development of therapies for patients with thymic developmental
defects, or reverse damage from aging, chemo or radiotherapies.
Further, maintenance of thymic epithelium ex vivo may allow in
vitro generation of differentiated T cells.
Supporting Information
Figure S1 Distribution of keratins in vivo after Rac1 dele-
tion. (A–D) K8, K5 and K14 localisation in wild type
thymus compared to K14CreERxRac1flox/flox (E–H) and
K5CrexRac1flox/flox (I–L). Scale bars 50 mm. (M–O) Impaired
thymic selection with increase of the CD4/CD8 double negative
population in tamoxifen treated K14CreERxRac1flox/flox mice
(N) and K5CrexRac1flox/flox (O) compared with tamoxifen
treated wild type mice (M).
(TIF)
Figure S2 Loss of Rac1 results in up-regulation of c-Myc. (A–D)
Tamoxifen treatment of K5CrexRac1flox/flox results in increase
immunofluorescence staining of c-myc in 6 week old remnant
thymi (A–D). Addition of tamoxifen to K14CreERxRac1flox/flox
(K14+Tam) derived Fetal Thymic Organ Cultures causes
increased c-Myc expression (E and F) compared to controls
(K14 no Tam) (B and C). Scale bars 50 mm.
(TIF)
Table S1 Proportions of CD3 and CD8 positive peripheral T
cells from spleens tamoxifen treated wild type, tamoxifen treated
K14KO and K5KO mice.
(DOCX)
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